Role of Hexokinase-1 in the survival of HIV-1-infected macrophages

References

• Locati M, Mantovani A, Sica A. Macrophage activation and polarization as an adaptive component of innate immunity. Adv Immunol. 2013; 120:163-84; PMID:24070384; http://dx.doi.org/10.1016/B978-0-12-417028-5.00006-5
   PubMed Web of Science ®Google Scholar
• Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 1986; 233:1089-93; PMID:3016903; http://dx.doi.org/10.1126/science.3016903
   PubMed Web of Science ®Google Scholar
• Cosenza MA, Zhao ML, Lee SC. HIV-1 expression protects macrophages and microglia from apoptotic death. Neuropathol Appl Neurobiol. 2004; 30:478-90; PMID:15488024; http://dx.doi.org/10.1111/j.1365-2990.2004.00563.x
   PubMed Web of Science ®Google Scholar
• Swingler S, Mann AM, Zhou J, Swingler C, Stevenson M. Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog. 2007; 3:1281-90; PMID:17907802; http://dx.doi.org/10.1371/journal.ppat.0030134
   PubMed Web of Science ®Google Scholar
• Le Douce V, Herbein G, Rohr O, Schwartz C. Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. Retrovirology. 2010; 7:32; PMID:20380694; http://dx.doi.org/10.1186/1742-4690-7-32
   PubMed Web of Science ®Google Scholar
• Busca A, Saxena M, Kumar A. Critical role for antiapoptotic Bcl-xL and Mcl-1 in human macrophage survival and cellular IAP1/2 (cIAP1/2) in resistance to HIV-Vpr-induced apoptosis. J Biol Chem. 2012; 287:15118-133; PMID:22403404; http://dx.doi.org/10.1074/jbc.M111.312660
   PubMed Web of Science ®Google Scholar
• Desplats P, Dumaop W, Smith D, Adame A, Everall I, Letendre S, Ellis R, Cherner M, Grant I, Masliah E. Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology. 2013; 80:1415-23; PMID:23486877; http://dx.doi.org/10.1212/WNL.0b013e31828c2e9e
   PubMed Web of Science ®Google Scholar
• Lamers SL, Fogel GB, Nolan DJ, McGrath MS, Salemi M. HIV-associated neuropathogenesis: a systems biology perspective for modeling and therapy. Biosystems. 2014; 119:53-61; PMID:24732754; http://dx.doi.org/10.1016/j.biosystems.2014.04.002
   PubMed Web of Science ®Google Scholar
• Dahiya S, Irish BP, Nonnemacher MR, Wigdahl B. Genetic variation and HIV-associated neurologic disease. Adv Virus Res. 2013; 87:183-240; PMID:23809924; http://dx.doi.org/10.1016/B978-0-12-407698-3.00006-5
   PubMed Web of Science ®Google Scholar
• Barrero CA, Datta PK, Sen S, Deshmane S, Amini S, Khalili K, Merali S. HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. PLoS One. 2013;8:e68376; PMID:23874603; http://dx.doi.org/10.1371/journal.pone.0068376
   PubMed Web of Science ®Google Scholar
• Wilson JE. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol. 2003; 206:2049-57; PMID:12756287; http://dx.doi.org/10.1242/jeb.00241
   PubMed Web of Science ®Google Scholar
• Xie GC, Wilson JE. Rat brain hexokinase: the hydrophobic N-terminus of the mitochondrially bound enzyme is inserted in the lipid bilayer. Arch Biochem Biophys 1988; 267:803-10; PMID:3214181; http://dx.doi.org/10.1016/0003-9861(88)90090-2
   PubMed Web of Science ®Google Scholar
• Sui D, Wilson JE. Structural determinants for the intracellular localization of the isozymes of mammalian hexokinase: intracellular localization of fusion constructs incorporating structural elements from the hexokinase isozymes and the green fluorescent protein. Arch Biochem Biophys 1997; 345:111-25; PMID:9281318; http://dx.doi.org/10.1006/abbi.1997.0241
   PubMed Web of Science ®Google Scholar
• Halestrap AP, McStay GP, Clarke SJ. The permeability transition pore complex: another view. Biochimie. 2002; 84:153-166; PMID:12022946; http://dx.doi.org/10.1016/S0300-9084(02)01375-5
   PubMed Web of Science ®Google Scholar
• Pastorino JG, Shulga N, Hoek JB. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem. 2002; 277:7610-18; PMID:11751859; http://dx.doi.org/10.1074/jbc.M109950200
   PubMed Web of Science ®Google Scholar
• Azoulay-Zohar H, Israelson A, Abu-Hamad S, Shoshan-Barmatz V. In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondriamediated apoptotic cell death. Biochem J 2004; 377:347-55; PMID:14561215; http://dx.doi.org/10.1042/BJ20031465
   PubMed Web of Science ®Google Scholar
• Cassol E, Alfano M, Biswas P, Poli G. Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J Leukoc Biol. 2006; 80:1018-30; PMID:16946020; http://dx.doi.org/10.1189/jlb.0306150
   PubMed Web of Science ®Google Scholar
• Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987; 238:800-02; PMID:3313729; http://dx.doi.org/10.1126/science.3313729
   PubMed Web of Science ®Google Scholar
• Bristow CL, Wolkowicz R, Trucy M, Franklin A, Di Meo F, Kozlowski MT, Winston R, Arnold RR. NF-kappaB signaling, elastase localization, and phagocytosis differ in HIV-1 permissive and nonpermissive U937 clones. J Immunol. 2008; 180:492-99; PMID:18097051; http://dx.doi.org/10.4049/jimmunol.180.1.492
   PubMed Web of Science ®Google Scholar
• Fernandez Larrosa PN, Croci DO, Riva DA, Bibini M, Luzzi R, Saracco M, Mersich SE, Rabinovich GA, Martinez Peralta L. Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway. Retrovirology. 2008; 5:19; PMID:18261236; http://dx.doi.org/10.1186/1742-4690-5-19
   PubMed Web of Science ®Google Scholar
• Olivares I, Ballester A, Lombardia L, Dominguez O, Lopez-Galindez C. Human immunodeficiency virus type 1 chronic infection is associated with different gene expression in MT-4, H9 and U937 cell lines. Virus Res. 2009; 139:22-31; PMID:19000723; http://dx.doi.org/10.1016/j.virusres.2008.09.010
   PubMed Web of Science ®Google Scholar
• Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, Gottlob K, Chandel NS, Thompson CB, Robey RB, Hay N. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell. 2004; 16:819-30; PMID:15574336; http://dx.doi.org/10.1016/j.molcel.2004.11.014
   PubMed Web of Science ®Google Scholar
• Sun L, Shukair S, Naik TJ, Moazed F, Ardehali H (2008) Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Mol Cell Biol. 2008; 28:1007-17; PMID:18039843; http://dx.doi.org/10.1128/MCB.00224-07
   PubMed Web of Science ®Google Scholar
• Wu R, Wyatt E, Chawla K, Tran M, Ghanefar M, Laakso M, Epting CL, Ardehali H. Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production. EMBO Mol Med. 2012; 4:633-46; PMID:22517678; http://dx.doi.org/10.1002/emmm.201200240
   PubMed Web of Science ®Google Scholar
• Connor RI, Chen BK, Choe S, Landau NR (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995 206:935-44; PMID:7531918; http://dx.doi.org/10.1006/viro.1995.1016
   PubMed Web of Science ®Google Scholar
• Chiara F, Castellaro D, Marin O, Petronilli V, Brusilow WS, Juhaszova M, Sollott SJ, Forte M, Bernardi P, Rasola A. Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels. PLoS One. 2008 19;3(3):e1852; PMID:18350175; http://dx.doi.org/10.1371/journal.pone.0001852
   PubMed Web of Science ®Google Scholar
• Robey RB, Hay N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 2005; 25:4683-96; http://dx.doi.org/10.1038/sj.onc.1209595
   Web of Science ®Google Scholar
• Nicholson DW, Thornberry NA. Caspases: Killer proteases. Trends Biochem. Sci. 1997; 22:299-306; PMID:9270303; http://dx.doi.org/10.1016/S0968-0004(97)01085-2
   PubMed Web of Science ®Google Scholar
• Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998; 281:1312-16; PMID:9721091; http://dx.doi.org/10.1126/science.281.5381.1312
   PubMed Web of Science ®Google Scholar
• Pinti M, Biswas P, Troiano L, Nasi M, Ferraresi R, Mussini C, Vecchiet J, Esposito R, Paganelli R, Cossarizza A. Different sensitivity to apoptosis in cells of monocytic or lymphocytic origin chronically infected with human immunodeficiency virus type-1. Experimental Biology and Medicine. 2003; 228:1346-54; PMID:14681550
   PubMed Web of Science ®Google Scholar
• Lum JJ, Badley AD. Resistance to apoptosis. Mechanism for the development of HIV reservoirs. Curr. HIV Res. 2003; 1:261-74; PMID:15046251; http://dx.doi.org/10.2174/1570162033485203
   PubMed Web of Science ®Google Scholar
• Kumar A, Abbas W, Herbein G. HIV-1 latency in monocytes/macrophages. Viruses. 2014; 6:1837-60; PMID:24759213; http://dx.doi.org/10.3390/v6041837
   PubMed Web of Science ®Google Scholar
• Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya CV. Up-regulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 1996; 70:199-206; PMID:8523526
   PubMed Web of Science ®Google Scholar
• Kiener PA, Davis PM, Starling GC, Mehlin C, Klebanoff SJ, Ledbetter JA, Liles WC. (1997) Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J. Exp. Med. 1997; 185:1511-16; PMID:9126933; http://dx.doi.org/10.1084/jem.185.8.1511
   PubMed Web of Science ®Google Scholar
• Guillemard E, Jacquemot C, Aillet F, Schmitt N, Barré-Sinoussi F, Israël N. (2004) Human immunodeficiency virus 1 favors the persistence of infection by activating macrophages through TNF. Virology 2004; 329:371-80; PMID:15518816; http://dx.doi.org/10.1016/j.virol.2004.08.030
   PubMed Web of Science ®Google Scholar
• Zhang M, Li X, Pang X, Ding L, Wood O, Clouse KA, Hewlett I, Dayton AI. Bcl-2 upregulation by HIV-1 Tat during infection of primary human macrophages in culture. J. Biomed. Sci. 2002; 9:133-39; PMID:11914580; http://dx.doi.org/10.1007/BF02256024
   PubMed Web of Science ®Google Scholar
• Olivetta E, Federico M. HIV-1 Nef protects human monocyte-derived macrophages from HIV1-induced apoptosis. Exp. Cell Res. 2006; 312:890-900; PMID:16445909; http://dx.doi.org/10.1016/j.yexcr.2005.12.003
   PubMed Web of Science ®Google Scholar
• Abbas W, Khan KA, Kumar A, Tripathy MK, Dichamp I, Keita M, Mahlknecht U, Rohr O, Herbein G. Blockade of BFA-mediated apoptosis in macrophages by the HIV-1 Nef protein. Cell Death Dis. 2014; 5:e1080; PMID:24556695; http://dx.doi.org/10.1038/cddis.2014.16
   PubMed Web of Science ®Google Scholar
• Lucas A, Kim Y, Rivera-Pabon O, Chae S, Kim DH, Kim B. Targeting the PI3K/Akt cell survival pathway to induce cell death of HIV-1 infected macrophages with alkylphospholipid compounds. PLoS One. 2010; 5:e13121; PMID:20927348; http://dx.doi.org/10.1371/journal.pone.0013121
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Kameoka M, Ota K, Itaya A, Ikuta K, Yoshihara K. Establishment of persistent infection with HIV-1 abrogates the caspase-3-dependent apoptotic signaling pathway in U937 cells. Experimental cell research. 1999; 247:514-24; PMID:10066379; http://dx.doi.org/10.1006/excr.1998.4376
   PubMed Web of Science ®Google Scholar
• King A, Gottlieb E. Glucose metabolism and programmed cell death: an evolutionary and mechanistic perspective. Curr Opin Cell Biol. 2009; 21:885-93; PMID:19850457; http://dx.doi.org/10.1016/j.ceb.2009.09.009
   PubMed Web of Science ®Google Scholar
• Hollenbaugh JA, Munger J, Kim B. Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysis. Virology. 2011; 415:153-59; PMID:21565377; http://dx.doi.org/10.1016/j.virol.2011.04.007
   PubMed Web of Science ®Google Scholar
• Linden M, Gellerfors P, Nelson BD. Pore protein and the hexokinase-binding protein from the outer membrane of rat liver mitochondria are identical. FEBS Lett. 1982; 141:189-92; PMID:6178620; http://dx.doi.org/10.1016/0014-5793(82)80044-6
   PubMed Web of Science ®Google Scholar
• Vyssokikh, MY, Brdiczka D. The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis. Acta Biochim. Pol 2003; 50:389-404; PMID:12833165
   PubMed Web of Science ®Google Scholar
• Pennington KN, Taylor JA, Bren GD, Paya CV. IkappaB kinase dependent chronic activation of NF-kappaB is necessary for p21(WAF1/Cip1) inhibition of differentiation-induced apoptosis of monocytes. Mol Cell Biol. 2001; 21:1930-41; PMID:11238929; http://dx.doi.org/10.1128/MCB.21.6.1930-1941.2001
   PubMed Web of Science ®Google Scholar
• Pastorino JG, Hoek JB. Regulation of hexokinase binding to VDAC. J Bioenerg Biomembr. 2008; 40:171-82; PMID:18683036; http://dx.doi.org/10.1007/s10863-008-9148-8
   PubMed Web of Science ®Google Scholar
• John S, Weiss JN, Ribalet B. Subcellular localization of hexokinases I and II directs the metabolic fate of glucose. PLoS One 2011; 6:e17674; PMID:21408025; http://dx.doi.org/10.1371/journal.pone.0017674
   PubMed Web of Science ®Google Scholar
• Cheng-Mayer C, Levy JA. Distinct biological and serological properties of human.immunodeficiency viruses from the brain. Ann Neurol. 1988; 23:S58-S61; PMID:3258140.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Ahmad S, Schneider BK, Allen CB, Chang LY, White CW. Elevated expression of hexokinase II protects human lung epithelial-like A549 cells against oxidative injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002; 283:L573-84; PMID:12169577
   PubMed Web of Science ®Google Scholar
• Shroff EH, Snyder CM, Budinger GR, Jain M, Chew TL, Khuon S, Perlman H, Chandel NS. BH3 peptides induce mitochondrial fission and cell death independent of BAX/BAK. PLoS One. 2009; 4:e5646; PMID:19468307; http://dx.doi.org/10.1371/journal.pone.0005646
   PubMed Web of Science ®Google Scholar